Verruca (Warts) Recruiting Phase 2 / 3 Trials for Human papillomavirus type 33 L1 capsid protein antigen (DB10311)

Back to Verruca (Warts)

Also known as: Verruca / Verruca, Warts / Warts / Wart / Other viral warts / Verruca vulgaris / Common wart / Viral warts / Common warts / Warts (viral) / Verruca (morphologic abnormality) / Wart (viral) / Verruca vulgaris (disorder) / Skin papilloma / Papilloma of skin (disorder) / Papilloma of skin / Papilloma skin

Indication	Status	Phase
DBCOND0060939 (Verruca (Warts))	Recruiting	2 / 3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT05625633	Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts	Treatment	Human papillomavirus type 11 L1 capsid protein antigen (DB10300) Human papillomavirus type 16 L1 capsid protein antigen (DB10301) Human papillomavirus type 18 L1 capsid protein antigen (DB10302) Human papillomavirus type 31 L1 capsid protein antigen (DB10310) Human papillomavirus type 33 L1 capsid protein antigen (DB10311) Human papillomavirus type 45 L1 capsid protein antigen (DB10312) Human papillomavirus type 52 L1 capsid protein antigen (DB10313) Human papillomavirus type 58 L1 capsid protein antigen (DB10314) Human papillomavirus type 6 L1 capsid protein antigen (DB10299)